[
Xenon Pharma’s azetukalner shows 53% seizure reduction in trial
[og_img]
https://www.investing.com/news/company-news/xenon-pharmas-azetukalner-shows-53-seizure-reduction-in-trial-93CH-4622259
Investing.com
Xenon Pharma’s azetukalner shows 53% seizure reduction in trial
Related articles




